FUVISTRA


Solution for Injection
scheduling status
S4
registration number
56/21.12/0245
What FUVISTRA contains
Each pre-filled syringe contains 250 mg/5 ml (5 % m/v) Fulvestrant.
other ingredients
Ethanol 96 % (alcohol) (Emprove), Benzyl alcohol (Parenteral Grade), Benzyl Benzoate, Castor oil Refined, Nitrogen.
Therapeutic classification
Pharmacotherapeutic group: Endocrine therapy, Antioestrogens, ATC code: L02BA03 A. 21.12 Hormone inhibitors.
© 2026 SAHPRA. ALL RIGHTS RESERVED